Atlas Venture https://atlasventure.com/ Mon, 06 May 2024 14:48:47 +0000 en-US hourly 1 https://ecskrgnm8g8.exactdn.com/wp-content/uploads/2023/06/Atlas-Favicon2.png?strip=all&lossy=0&resize=32%2C32&ssl=1 Atlas Venture https://atlasventure.com/ 32 32 Mariana Oncology’s Radiopharm Platform Acquired By Novartis https://atlasventure.com/2024/05/06/mariana-oncologys-radiopharm-platform-acquired-by-novartis/ https://atlasventure.com/2024/05/06/mariana-oncologys-radiopharm-platform-acquired-by-novartis/#respond Mon, 06 May 2024 14:46:08 +0000 https://atlasventure.com/?p=1865 The post Mariana Oncology’s Radiopharm Platform Acquired By Novartis appeared first on Atlas Venture.

]]> The post Mariana Oncology’s Radiopharm Platform Acquired By Novartis appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/05/06/mariana-oncologys-radiopharm-platform-acquired-by-novartis/feed/ 0 Stars and Scars… Some Lessons Learned About Leadership https://atlasventure.com/2024/05/02/stars-and-scars-some-lessons-learned-about-leadership/ https://atlasventure.com/2024/05/02/stars-and-scars-some-lessons-learned-about-leadership/#respond Thu, 02 May 2024 14:46:28 +0000 https://atlasventure.com/?p=1866 The post Stars and Scars… Some Lessons Learned About Leadership appeared first on Atlas Venture.

]]> The post Stars and Scars… Some Lessons Learned About Leadership appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/05/02/stars-and-scars-some-lessons-learned-about-leadership/feed/ 0 Novartis Buys Mariana Oncology in $1B Acquisition, Bolsters Radiopharma Assets https://atlasventure.com/2024/05/02/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets/ https://atlasventure.com/2024/05/02/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets/#respond Thu, 02 May 2024 14:43:38 +0000 https://atlasventure.com/?p=1864 The post Novartis Buys Mariana Oncology in $1B Acquisition, Bolsters Radiopharma Assets appeared first on Atlas Venture.

]]> The post Novartis Buys Mariana Oncology in $1B Acquisition, Bolsters Radiopharma Assets appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/05/02/novartis-buys-mariana-oncology-in-1b-acquisition-bolsters-radiopharma-assets/feed/ 0 The Biotech Startup Contraction Continues… And That’s A Good Thing https://atlasventure.com/2024/04/26/the-biotech-startup-contraction-continues-and-thats-a-good-thing/ https://atlasventure.com/2024/04/26/the-biotech-startup-contraction-continues-and-thats-a-good-thing/#respond Fri, 26 Apr 2024 14:47:06 +0000 https://atlasventure.com/?p=1867 The post The Biotech Startup Contraction Continues… And That’s A Good Thing appeared first on Atlas Venture.

]]> The post The Biotech Startup Contraction Continues… And That’s A Good Thing appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/26/the-biotech-startup-contraction-continues-and-thats-a-good-thing/feed/ 0 Pharmacology: The Anchor for Nearly Every Diligence https://atlasventure.com/2024/04/25/pharmacology-the-anchor-for-nearly-every-diligence/ https://atlasventure.com/2024/04/25/pharmacology-the-anchor-for-nearly-every-diligence/#respond Thu, 25 Apr 2024 14:47:33 +0000 https://atlasventure.com/?p=1868 The post Pharmacology: The Anchor for Nearly Every Diligence appeared first on Atlas Venture.

]]> The post Pharmacology: The Anchor for Nearly Every Diligence appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/25/pharmacology-the-anchor-for-nearly-every-diligence/feed/ 0 Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor https://atlasventure.com/2024/04/24/day-ones-ojemda-gets-fda-accelerated-approval-for-pediatric-brain-tumor/ https://atlasventure.com/2024/04/24/day-ones-ojemda-gets-fda-accelerated-approval-for-pediatric-brain-tumor/#respond Wed, 24 Apr 2024 20:40:18 +0000 https://atlasventure.com/?p=1862 The post Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor appeared first on Atlas Venture.

]]> The post Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/24/day-ones-ojemda-gets-fda-accelerated-approval-for-pediatric-brain-tumor/feed/ 0 Deconstructing the Diligence Process: An Approach to Vetting New Product Theses https://atlasventure.com/2024/04/24/deconstructing-the-diligence-process-an-approach-to-vetting-new-product-theses/ https://atlasventure.com/2024/04/24/deconstructing-the-diligence-process-an-approach-to-vetting-new-product-theses/#respond Wed, 24 Apr 2024 14:48:27 +0000 https://atlasventure.com/?p=1869 The post Deconstructing the Diligence Process: An Approach to Vetting New Product Theses appeared first on Atlas Venture.

]]> The post Deconstructing the Diligence Process: An Approach to Vetting New Product Theses appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/24/deconstructing-the-diligence-process-an-approach-to-vetting-new-product-theses/feed/ 0 Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing https://atlasventure.com/2024/04/09/two-ex-bluebird-leaders-launch-nvelop-with-100m-to-tackle-the-biggest-problem-in-gene-editing/ https://atlasventure.com/2024/04/09/two-ex-bluebird-leaders-launch-nvelop-with-100m-to-tackle-the-biggest-problem-in-gene-editing/#respond Tue, 09 Apr 2024 14:31:08 +0000 https://atlasventure.com/?p=1856 The post Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing appeared first on Atlas Venture.

]]> The post Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/09/two-ex-bluebird-leaders-launch-nvelop-with-100m-to-tackle-the-biggest-problem-in-gene-editing/feed/ 0 Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program https://atlasventure.com/2024/04/03/obsidian-therapeutics-rakes-in-160m-for-solid-tumor-cell-therapy-program/ https://atlasventure.com/2024/04/03/obsidian-therapeutics-rakes-in-160m-for-solid-tumor-cell-therapy-program/#respond Wed, 03 Apr 2024 14:32:19 +0000 https://atlasventure.com/?p=1858 The post Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program appeared first on Atlas Venture.

]]> The post Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/03/obsidian-therapeutics-rakes-in-160m-for-solid-tumor-cell-therapy-program/feed/ 0 Diagonal Therapeutics Raises $128 Million to Discover Agonist Antibodies https://atlasventure.com/2024/04/03/diagonal-therapeutics-raises-128-million-to-discover-agonist-antibodies/ https://atlasventure.com/2024/04/03/diagonal-therapeutics-raises-128-million-to-discover-agonist-antibodies/#respond Wed, 03 Apr 2024 14:31:34 +0000 https://atlasventure.com/?p=1857 The post Diagonal Therapeutics Raises $128 Million to Discover Agonist Antibodies appeared first on Atlas Venture.

]]> The post Diagonal Therapeutics Raises $128 Million to Discover Agonist Antibodies appeared first on Atlas Venture.

]]> https://atlasventure.com/2024/04/03/diagonal-therapeutics-raises-128-million-to-discover-agonist-antibodies/feed/ 0